| Bone metastasis risk factors in breast cancer C Pulido, I Vendrell, AR Ferreira, S Casimiro, A Mansinho, I Alho, L Costa Ecancermedicalscience 11, 2017 | 106 | 2017 |
| Treatment of cancer pain by targeting cytokines I Vendrell, D Macedo, I Alho, MR Dionísio, L Costa Mediators of inflammation 2015, 2015 | 56 | 2015 |
| Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases AR Ferreira, M Bettencourt, I Alho, AL Costa, AR Sousa, A Mansinho, ... Journal of Bone Oncology 6, 16-21, 2017 | 31 | 2017 |
| Levels of circulating fibroblast growth factor 23 (FGF23) and prognosis in cancer patients with bone metastases A Mansinho, AR Ferreira, S Casimiro, I Alho, I Vendrell, AL Costa, ... International Journal of Molecular Sciences 20 (3), 695, 2019 | 24 | 2019 |
| Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancer I Vendrell, AR Ferreira, AN Abrunhosa-Branquinho, PM Semedo, ... Medicine (Baltimore) 97 (30), e11592, 2018 | 15 | 2018 |
| Molecular subtype assay to reveal anti-EGFR response sub-clones in colorectal cancer (CRC). E Fontana, G Nyamundanda, D Cunningham, C Ragulan, F Sclafani, ... Journal of Clinical Oncology 36, no. 4_suppl (February 1 2018) 658-658., 2018 | 11 | 2018 |
| Bone metastasis risk factors in breast cancer. Ecancermedicalscience. 2017; 11: 715 C Pulido, I Vendrell, AR Ferreira, S Casimiro, A Mansinho, I Alho, L Costa Crossref Şekil 4, 2017 | 8 | 2017 |
| Radionuclides in oncology clinical practice–review of the literature HL Pais, I Alho, I Vendrell, A Mansinho, L Costa Dalton Transactions 46 (42), 14475-14487, 2017 | 8 | 2017 |
| The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases A Ferreira, I Alho, I Vendrell, M Melo, R Brás, AL Costa, AR Sousa, ... Oncotarget 7 (27), 41380, 2016 | 6 | 2016 |
| Hematological profile: A prognosis tool in melanoma patients treated with immunotherapy SL Martins, P Miguel-Semedo, DA Martins-Branco, AM Monteiro, ... J Clin Oncol 37 (8_suppl), 135, 2019 | 5 | 2019 |
| Retrospective multicenter cohort of nab-paclitaxel plus gemcitabine (NG) after FOLFIRINOX failure in advanced pancreatic cancer (APC): Effectiveness, tolerability, and response … I Vendrell, AR Ferreira, C Pulido, A Parmanande, F Ferreira Da Silva, ... Journal of Clinical Oncology 35 (15_suppl), e15743-e15743, 2017 | 3 | 2017 |
| 1320P Impact of body mass index (BMI) in non-small cell lung cancer patients treated with anti PD-1 immunotherapy (IO): a retrospective cohort study AC Bravo, SL Lobo-Martins, I Vendrell, AB Mansinho, C Melo-Alvim, ... Annals of Oncology 31, S852, 2020 | 2 | 2020 |
| EP08. 02-053 Non-small Cell Lung Cancer withMETExon14 Skipping Mutation: Literature Review of Real-World Evidence Data E Teixeira, F Estevinho, I Moital, S Mondal, M Kalra, I Vendrell Journal of Thoracic Oncology 17 (9), S423, 2022 | | 2022 |
| 7 Prognostic factors for overall survival in patients with advanced melanoma treated with Anti-PD-1 therapy–the melimmune score S Lobo-Martins, D Martins-Branco, PM Semedo, CM Alvim, AM Monteiro, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), A7-A7, 2020 | | 2020 |
| P-150 Khorana and PROTECHT scores in predicting the risk of venous thromboembolism in pancreatic cancer: Which performed better? S Dâmaso, R Paiva, I Pinho, M Martins, R Brás, A Costa, A Quintela, ... Annals of Oncology 31, S138, 2020 | | 2020 |
| P-151 The impact of adjuvant chemotherapy regimens in stage II colon cancer (CC) patients S Lobo-Martins, M Martins, P Semedo, C Alvim, HL Pais, R Paiva, C Pinto, ... Annals of Oncology 31, S139, 2020 | | 2020 |
| Identification of a nanostring signature that differentiates early pancreatic cancers according to stromal composition and predicts clinical outcome F Sclafani, L Cascione, D Cunningham, K Young, P Carotenuto, ... Annals of Oncology 30, iv110-iv111, 2019 | | 2019 |
| Levels of circulating fibroblast growth factor (FGF) 23 and prognosis of cancer patients with bone metastasis AB Mansinho, AR Ferreira, S Casimiro, I Alho, I Vendrell, AL Costa, ... Annals of Oncology 29, viii55, 2018 | | 2018 |
| Analysis of cancer outcomes after desensitization protocols in patients with metastatic disease C Pulido, J Caiado, AR Ferreira, I Vendrell, AL Costa, A Mendes, ... Annals of Oncology 27, vi515, 2016 | | 2016 |
| Secreted YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases M Bettencourt, A Ferreira, I Alho, CA Lucia, AR Sousa, A Mansinho, ... Bone Abstracts 5, 2016 | | 2016 |
Irina AlhoFaculdade de Medicina ULisboaVerified email at medicina.ulisboa.pt
